Conor McNamara
Stock Analyst at RBC Capital
(1.16)
# 3,798
Out of 5,182 analysts
128
Total ratings
31.07%
Success rate
-13.75%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $59.23 | +23.25% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.39 | +47.49% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $208.40 | +22.36% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.64 | +82.93% | 4 | Aug 7, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $8.52 | +99.53% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $134.50 | -6.32% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $299.02 | +36.78% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $300.23 | +36.23% | 14 | Aug 1, 2025 | |
| RGEN Repligen | Maintains: Outperform | $193 → $204 | $131.21 | +55.48% | 12 | Jul 30, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $526.60 | +20.96% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $194.75 | +28.37% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $12.71 | +379.94% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $5.28 | +32.58% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $59.23
Upside: +23.25%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.39
Upside: +47.49%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $208.40
Upside: +22.36%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.64
Upside: +82.93%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.52
Upside: +99.53%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $134.50
Upside: -6.32%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $299.02
Upside: +36.78%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $300.23
Upside: +36.23%
Repligen
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $131.21
Upside: +55.48%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $526.60
Upside: +20.96%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $194.75
Upside: +28.37%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $12.71
Upside: +379.94%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $5.28
Upside: +32.58%